Break Up or Time Out?
“Like many companies, Dexcom’s Board and management team regularly review opportunities to enhance stockholder value and create benefits for customers, including through mergers and acquisitions. It is generally our policy not to comment on rumors or speculation, however, in light of recent sustained media and market speculation as well as the upcoming American Diabetes Association conference, we wish to confirm that Dexcom is not in active discussions regarding a merger transaction at this time. We do not intend to comment further on this topic, and we assume no obligation to make any further announcement or disclosure should circumstances change . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.